AvePoint Sees Q3 Sales $128.200M-$130.200M vs $133.613M Est

Benzinga Newsdesk www.benzinga.com Positive 77.4%

Neg 0% Neu 0% Pos 77.4%

AvePoint (NASDAQ:AVPT) sees Q3 sales of $128.200 million-$130.200 million vs $133.613 million analyst estimate.

Comments

No comments yet. Be the first!